Osteoclastic metabolism of 25(OH)-vitamin D3: A potential mechanism for optimization of bone resorption

Endocrinology

Volumn 151, Issue 10, 2010, Pages 4613-4625

  Kogawa, Masakazu ^a   Findlay, David M ^a,b   Anderson, Paul H ^b   Ormsby, Renee ^a   Vincent, Cristina ^a   Morris, Howard A ^b,c   Atkins, Gerald J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b HANSON INSTITUTE   (Australia)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIDIOL 1 MONOOXYGENASE; CALCIFEDIOL; CALCITRIOL; COLONY STIMULATING FACTOR 1; EPHRIN B2; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR NFAT; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE; UPREGULATION; VITAMIN D METABOLISM; ANIMAL; ANTAGONISTS AND INHIBITORS; BONE DEVELOPMENT; CELL DIFFERENTIATION; DRUG EFFECTS; ETIOLOGY; GENE SILENCING; GENETICS; LEUKOCYTE; MACROPHAGE; METABOLISM; PHYSIOLOGY;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ANIMALS; BONE RESORPTION; CALCIFEDIOL; CALCITRIOL; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; LEUKOCYTES; MACROPHAGES; MICE; OSTEOCLASTS; OSTEOGENESIS; RECEPTORS, CALCITRIOL;

EID: 77957262797     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0334     Document Type: Article

References (58)

1. Anderson PH, Atkins GJ 2008 The skeleton as an intracrine organ for vitamin D metabolism. Mol Aspects Med 29:397-406
2. Horwood NJ, Elliott J, Martin TJ, Gillespie MT 1998 Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 139:4743-4746
3. Okada Y, Morimoto I, Ura K, Watanabe K, Eto S, Kumegawa M, Raisz L, Pilbeam C, Tanaka Y 2002 Cell-to-cell adhesion via intercellular adhesion molecule-1 and leukocyte function-associated antigen- 1 pathway is involved in 1α,25(OH)2D3, PTH and IL-1α- induced osteoclast differentiation and bone resorption. Endocr J 49:483-495
4. Mimura H, Cao X, Ross FP, Chiba M, Teitelbaum SL 1994 1,25- Dihydroxyvitamin D3 transcriptionally activates the β3-integrin subunit gene in avian osteoclast precursors. Endocrinology 134: 1061-1066 (Pubitemid 24085551)
5. Medhora MM, Teitelbaum S, Chappel J, Alvarez J, Mimura H, Ross FP, Hruska K 1993 1α,25-Dihydroxyvitamin D3 up-regulates expression of the osteoclast integrin αvβ3. J Biol Chem 268:1456-1461
6. Cao X, Ross FP, Zhang L, MacDonald PN, Chappel J, Teitelbaum SL 1993 Cloning of the promoter for the avian integrin β3 subunit gene and its regulation by 1,25-dihydroxyvitamin D3. J Biol Chem 268:27371-27380 (Pubitemid 24006460)
7. Andersson G, Johansson EK 1996 Adhesion of human myelomonocytic (HL-60) cells induced by 1,25-dihydroxyvitamin D3 and phorbol myristate acetate is dependent on osteopontin synthesis and the αvβ3 integrin. Connect Tissue Res 35:163-171 (Pubitemid 27118848)
8. Kido S, Inoue D, Hiura K, Javier W, Ito Y, Matsumoto T 2003 Expression ofRANKis dependent upon differentiation into the macrophage/ osteoclast lineage: induction by 1α,25-dihydroxyvitamin D3 and TPA in a human myelomonocytic cell line, HL60. Bone 32:621-629 (Pubitemid 37297386)
9. Vincent C, Kogawa M, Findlay DM, Atkins GJ 2009 The generation of osteoclasts from RAW 264.7 precursors in defined, serum-free conditions. J Bone Miner Metab 27:114-119
10. Anderson PH, Sawyer RK, Moore AJ, May BK, O'Loughlin PD, Morris HA 2008 Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model. J Bone Miner Res 23:1789-1797
11. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B 2004 Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 116:634-639 (Pubitemid 38490539)
12. Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A 2007 Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 370:657-666 (Pubitemid 47285316)
13. Dardenne O, Prud'homme J, Glorieux FH, St-Arnaud R 2004 Rescue of the phenotype of CYP27B1 (1α-hydroxylase)-deficient mice. J Steroid Biochem Mol Biol 89-90:327-330
14. Panda DK, Miao D, Bolivar I, Li J, Huo R, Hendy GN, Goltzman D 2004 Inactivation of the 25-hydroxyvitamin D 1α-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 279:16754-16766 (Pubitemid 38509378)
15. Liu H, Guo J, Wang L, Chen N, Karaplis A, Goltzman D, Miao D 2009 Distinctive anabolic roles of 1,25-dihydroxyvitamin D(3) and parathyroid hormone in teeth and mandible versus long bones. J Endocrinol 203:203-213
16. Anderson PH, Atkins GJ, Findlay DM, Oloughlin PD, Welldon K, Vincent C, Morris HA 2007 RNAi-mediated silencing of CYP27B1 abolishes 1,25(OH)2D3 synthesis and reduces osteocalcin and CYP24 mRNA expression in human osteosarcoma (HOS) cells. J Steroid Biochem Mol Biol 103:601-605 (Pubitemid 46401351)
17. Atkins GJ, Anderson PH, Findlay DM, Welldon KJ, Vincent C, Zannettino AC, O'Loughlin PD, Morris HA 2007 Metabolism of vitamin D(3) in human osteoblasts: evidence for autocrine and paracrine activities of 1α,25-dihydroxyvitamin D(3). Bone 40: 1517-1528
18. Adams JS, Beeker TG, Hongo T, Clemens TL 1990 Constitutive expression of a vitamin D 1-hydroxylase in a myelomonocytic cell line: a model for studying 1,25-dihydroxyvitamin D production in vitro. J Bone Miner Res 5:1265-1269
19. Dusso AS, Finch J, Brown A, Ritter C, Delmez J, Schreiner G, Slatopolsky E 1991 Extrarenal production of calcitriol in normal and uremic humans. J Clin Endocrinol Metab 72:157-164 (Pubitemid 21921670)
20. Reichel H, Koeffler HP, Norman AW 1987 Synthesis in vitro of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by interferon- γ-stimulated normal human bone marrow and alveolar macrophages. J Biol Chem 262:10931-10937
21. van Driel M, Koedam M, Buurman CJ, Hewison M, Chiba H, Uitterlinden AG, Pols HA, van Leeuwen JP 2006 Evidence for auto/ paracrine actions of vitamin D in bone: 1α-hydroxylase expression and activity in human bone cells. FASEB J 20:2417-2419
22. Fujikawa Y, Quinn JM, Sabokbar A, McGee JO, Athanasou NA 1996 The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 137:4058-4060 (Pubitemid 26284685)
23. Massey HM, Flanagan AM 1999 Human osteoclasts derive from CD14-positive monocytes. Br J Haematol 106:167-170
24. Shalhoub V, Elliott G, Chiu L, Manoukian R, Kelley M, Hawkins N, Davy E, Shimamoto G, Beck J, Kaufman SA, Van G, Scully S, Qi M, Grisanti M, Dunstan C, Boyle WJ, Lacey DL 2000 Characterization of osteoclast precursors in human blood. Br J Haematol 111:501-512
25. Kogawa M, Anderson PH, Findlay DM, Morris HA, Atkins GJ 2010 The metabolism of 25-(OH)vitamin D(3) by osteoclasts and their precursors regulates the differentiation of osteoclasts. J Steroid Biochem Mol Biol 121:277-280
26. Atkins GJ, Kostakis P, Vincent C, Farrugia AN, Houchins JP, Findlay DM, Evdokiou A, Zannettino AC 2006 RANK expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone. J Bone Miner Res 21: 1339-1349 (Pubitemid 44300040)
27. Vincent C, Findlay DM, Welldon KJ, Wijenayaka AR, Zheng TS, Haynes DR, Fazzalari NL, Evdokiou A, Atkins GJ 2009 Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFα induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. J Bone Miner Res 24:1434-1449
28. Atkins GJ, Bouralexis S, Haynes DR, Graves SE, Geary SM, Evdokiou A, Zannettino AC, Hay S, Findlay DM 2001 Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone. Bone 28:370-377 (Pubitemid 32385408)
29. Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, Demay MB 1999 Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 140:4982-4987
30. Zhao C, Irie N, Takada Y, Shimoda K, Miyamoto T, Nishiwaki T, Suda T, Matsuo K 2006 Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab 4:111-121
31. Panda DK, Miao D, Tremblay ML, Sirois J, Farookhi R, Hendy GN, Goltzman D 2001 Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci USA 98:7498-7503 (Pubitemid 32567977)
32. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ 1999 Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96: 3540-3545
33. Need AG 2006 Bone resorption markers in vitamin D insufficiency. Clin Chim Acta 368:48-52
34. Need AG, Horowitz M, Morris HA, Moore R, Nordin C 2007 Seasonal change in osteoid thickness and mineralization lag time in ambulant patients. J Bone Miner Res 22:757-761 (Pubitemid 351339105)
35. Anderson PH, Sawyer RK, May BK, O'Loughlin PD, Morris HA 2007 25-Hydroxyvitamin D requirement for maintaining skeletal health utilising a Sprague-Dawley rat model. J Steroid Biochem Mol Biol 103:592-595
36. Hamilton JA 2008 Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 8:533-544
37. Arai F, Miyamoto T, Ohneda O, Inada T, Sudo T, Brasel K, Miyata T, Anderson DM, Suda T 1999 Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors. J Exp Med 190:1741-1754 (Pubitemid 30013841)
38. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T 2002 Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3:889-901 (Pubitemid 35460788)
39. Takayanagi H 2007 The role of NFAT in osteoclast formation. Ann NY Acad Sci 1116:227-237
40. Kim K, Kim JH, Lee J, Jin HM, Lee SH, Fisher DE, Kook H, Kim KK, Choi Y, Kim N 2005 Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. J Biol Chem 280:35209-35216 (Pubitemid 41532708)
41. Findlay DM 2006 Regulation of cell growth mediated by the calcitonin receptor. Cell Mol Biol (Noisy-le-grand) 52:3-8 (Pubitemid 44147433)
42. Hayman AR 2008 Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy. Autoimmunity 41:218-223
43. Itonaga I, Sabokbar A, Neale SD, Athanasou NA 1999 1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors. Biochem Biophys Res Commun 264:590-595
44. Takasu H, Sugita A, Uchiyama Y, Katagiri N, Okazaki M, Ogata E, Ikeda K 2006 c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs. J Clin Invest 116: 528-535 (Pubitemid 43228371)
45. LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J 1999 Occult vitaminDdeficiency in postmenopausal U.S.women with acute hip fracture. JAMA 281:1505-1511 (Pubitemid 29200934)
46. Morris HA, Morrison GW, Burr M, Thomas DW, Nordin BE 1984 Vitamin D and femoral neck fractures in elderly South Australian women. Med J Aust 140:519-521 (Pubitemid 14085984)
47. Need AG, O'Loughlin PD, Morris HA, Horowitz M, Nordin BE 2004 The effects of age and other variables on serum parathyroid hormone in postmenopausal women attending an osteoporosis center. J Clin Endocrinol Metab 89:1646-1649 (Pubitemid 38507915)
48. Hu YS, Zhou H, Myers D, Quinn JM, Atkins GJ, Ly C, Gange C, Kartsogiannis V, Elliott J, Kostakis P, Zannettino AC, Cromer B, McKinstry WJ, Findlay DM, Gillespie MT, Ng KW 2004 Isolation of a human homolog of osteoclast inhibitory lectin that inhibits the formation and function of osteoclasts. J Bone Miner Res 19:89-99
49. Blair HC, Athanasou NA 2004 Recent advances in osteoclast biology and pathological bone resorption. Histol Histopathol 19:189-199
50. Miyamoto T 2006 The dendritic cell-specific transmembrane protein DC-STAMP is essential for osteoclast fusion and osteoclast bone-resorbing activity. Mod Rheumatol 16:341-342 (Pubitemid 44921579)
51. Blair HC, Zaidi M 2006 Osteoclastic differentiation and function regulated by old and new pathways. Rev Endocr Metab Disord 7:23-32 (Pubitemid 46044347)
52. Lee BS, Holliday LS, Krits I, Gluck SL 1999 Vacuolar H+-ATPase activity and expression in mouse bone marrow cultures. J Bone Miner Res 14:2127-2136 (Pubitemid 30026962)
53. Boyan BD, Dean DD, Sylvia VL, Schwartz Z 2003 Steroid hormone action in musculoskeletal cells involves membrane receptor and nuclear receptor mechanisms. Connect Tissue Res 44(Suppl 1):130-135 (Pubitemid 36395434)
54. Boyan BD, Schwartz Z 2009 1,25-Dihydroxy vitamin D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60-activated matrix vesicle matrix metalloproteinases. Cells Tissues Organs 189:70-74
55. Atkins GJ, Haynes DR, Geary SM, Loric M, Crotti TN, Findlay DM 2000 Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation. Bone 26:653-661
56. Haynes DR, Atkins GJ, Loric M, Crotti TN, Geary SM, Findlay DM 1999 Bidirectional signaling between stromal and hemopoietic cells regulates interleukin-1 expression during human osteoclast formation. Bone 25:269-278 (Pubitemid 29406052)
57. Atkins GJ, Kostakis P, Pan B, Farrugia A, Gronthos S, Evdokiou A, Harrison K, Findlay DM, Zannettino AC 2003 RANKL expression is related to the differentiation state of human osteoblasts. J Bone Miner Res 18:1088-1098 (Pubitemid 37294947)
58. Atkins GJ, Bouralexis S, Evdokiou A, Hay S, Labrinidis A, Zannettino AC, Haynes DR, Findlay DM 2002Humanosteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis. Bone 31:448-456